Coronary artery disease in lung transplant patients

Area of Science:

• Cardiology
• Pulmonology
• Transplantation Medicine

Background:

• Coronary artery disease (CAD) frequently co-exists with end-stage lung disease.
• Historically, CAD was a contraindication for lung transplantation, but advances in revascularization have changed this.
• Current literature shows inconsistencies in guidelines for managing ischemic cardiac burden in lung transplant recipients.

Purpose of the Study:

• To review current data on perioperative evaluation for coronary artery disease in lung transplant candidates.
• To analyze revascularization strategies and their impact on outcomes.
• To summarize postoperative management and survival rates for lung transplant recipients with varying degrees of CAD.

Main Methods:

• Systematic review of existing literature.
• Analysis of perioperative cardiac evaluation protocols.
• Evaluation of revascularization techniques (e.g., percutaneous coronary intervention, coronary artery bypass grafting).
• Assessment of postoperative management and long-term survival data.

Main Results:

• Modern revascularization techniques enable lung transplantation in patients with CAD.
• Significant discrepancies exist in perioperative cardiac risk assessment and management guidelines.
• Data on optimal revascularization timing and strategy in this population is evolving.

Conclusions:

• Lung transplantation is feasible in selected patients with CAD.
• Standardized guidelines for perioperative cardiac evaluation and management are needed.
• Further research is required to optimize outcomes and survival in lung transplant recipients with coronary artery disease.